A detailed history of Capula Management LTD transactions in Arvinas, Inc. stock. As of the latest transaction made, Capula Management LTD holds 31,552 shares of ARVN stock, worth $709,288. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,552
Previous 24,752 27.47%
Holding current value
$709,288
Previous $658,000 18.09%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.66 - $32.73 $160,888 - $222,563
6,800 Added 27.47%
31,552 $777,000
Q2 2024

Aug 05, 2024

BUY
$24.46 - $40.4 $605,433 - $999,980
24,752 New
24,752 $658,000
Q3 2023

Nov 03, 2023

BUY
$19.64 - $28.21 $808,382 - $1.16 Million
41,160 New
41,160 $808,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.2B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.